Lobe Sciences Ltd. (CSE:LOBE)
0.0500
0.00 (0.00%)
Nov 20, 2026, 11:11 AM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 16.98 million as of November 20, 2026. It is the 40,001st most valuable company in the world and the 1,282nd biggest in Canada. Its market cap has increased by 40.00% in one year.
Market Cap
16.98M
Enterprise Value
13.43M
Revenue
n/a
Global Rank
Country Rank
#1,282 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 17.41M to 16.98M, a decrease of -2.50%. That is a compound annual growth rate of -0.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 16.98M | 40.00% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 20.21M |
| Defence Therapeutics | 19.41M |
| The More Life Company | 18.28M |
| Devonian Health Group | 17.52M |
| Alzai Health | 17.17M |
| Medicenna Therapeutics | 16.61M |
| Pharmala Biotech Holdings | 14.81M |
| Rapid Dose Therapeutics | 13.09M |